- November 2, 2019
- Posted by: amir
- Category: Uncategorized
TimeStamp’s mission is to transform the assessment of patients with uncontrolled asthma or COPD, by providing physicians (and payers) with a simple tool to help distinguish poor treatment response from poor adherence to inhaler therapy
Our technology is an electronic smart sticker product that records the usage history and is adaptable to most inhalers currently on the market. No cooperation from patients is required as the monitoring and recording process is completely automatic and transparent
Placing a TimeStamp™ equipped inhaler near a physician’s smartphone/computer displays adherence pattern and enables informed decision making
TimeStamp smart stickers are engineered to be:
Usage recording >3 months
History stored permanently (even when battery is dead)
Gad Riesenfeld PHD
Chairman & CEO
Gad was the President of Pharmos Corporation (NASDAQ) and a Co-Founder of Otic Pharma (NASDAQ) He served on the board of directors of bio-pharmaceutical companies and led combined international efforts in Scientific and Clinical Research.
Prof. David Price
Chief Medical Officer
David is Managing Director of Observational & Pragmatic Research Institute and Optimum Patient Care . He is Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen (Scotland). His area of interest lies in ‘real-life’ research. He has authored over 400 peer-reviewed publications.
Ian is a serial entrepreneur in the medical device field, specializing in drug-delivery and diagnostic devices. Co-founder of SteadyMed (NASDAQ), and RespiDx Ltd. Experienced in taking products involving multiple technologies from concept through to implementation, and securing their IP position.
Amir was Global Marketing Director at Teva Respiratory. With over 30 years of experience in management roles with leading global respiratory companies (GSK,AZ,BI and others)